Evidence map›Paper›PMID 28966461›Full record

ArticleProceedings (Baylor University. Medical Center)2017

Natural killer/T-cell lymphoma invading the orbit and globe.

Lance J Lyons, Ivan Vrcek, Marie Somogyi, Kevin Taheri, Joan H Admirand, Saradha Chexal, Demetrius F Loukas, Tanuj Nakra

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lance J LyonsUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Ivan VrcekUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Marie SomogyiUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Kevin TaheriUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Joan H AdmirandUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Saradha ChexalUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Demetrius F LoukasUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
Tanuj NakraUniversity of Texas at Austin Dell Medical School, Austin, Texas (Lyons); TOC Eye and Face, Austin, Texas (Vrcek, Somogyi, Nakra); ENT and Allergy Center of Austin, Round Rock, TX (Taheri); Seton Medical Center Austin, Austin, Texas (Admirand); Retina Consultants of Austin, Austin, Texas (Chexal); and Texas Oncology, Austin, Texas (Loukas).
ENT and Allergy · USRetina Consultants of Houston · USSeton Medical Center Austin · USTexas Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer/T-cell lymphomas are extremely rare and carry high mortality rates. Epidemiologically, these cancers tend to affect mainly Asian and South American patients and are associated with Epstein-Barr virus seropositivity. This report details a 78-year-old Vietnamese woman who presented initially with vitritis of unknown cause, but later developed proptosis and conjunctival involvement as her disease spread. Biopsies of the orbit, ethmoid sinus, and conjunctiva were found to be significant for natural killer/T-cell lymphoma. The case highlights the diagnostic difficulty of this tumor given its rarity and ability to mimic other disorders.

Identifiers

PMID28966461
PMCPMC5595391
OpenAlexW2794060967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.